AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis

Under the terms of the deal, Scripps will run preclinical R&D, and in some cases, Phase I clinical trials. AbbVie will have an exclusive option to continue development and possible commercialization activities.